Evidence map›Paper›PMID 27663860›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.

Mikako Hisamichi, Atsuko Kamijo-Ikemori, Takeshi Sugaya, Daisuke Ichikawa, Takayuki Natsuki, Seiko Hoshino, Kenjiro Kimura, Yugo Shibagaki

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mikako HisamichiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Atsuko Kamijo-IkemoriDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan; a2kamijo@marianna-u.ac.jp.
Takeshi SugayaDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Daisuke IchikawaDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Takayuki NatsukiInstitute for Ultrastructural Morphology, St. Marianna University School of Medicine, Kawasaki, Japan.
Seiko HoshinoDepartment of Anatomy, St. Marianna University School of Medicine, Kawasaki, Japan.
Kenjiro KimuraDepartment of Internal Medicine, Japan Community Health Care Organization, Tokyo Takanawa Hospital, Tokyo, Japan.
Yugo ShibagakiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
St. Marianna University School of Medicine · JPJapan Community Healthcare Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the in vivo role of angiotensin II type 1a (AT1a) receptor in renal damage as a result of hypertension by using transgenic mice with AT1a receptor gene disruption. Transgenic mice that express human liver-type fatty acid binding protein (L-FABP) with or without disruption of the AT1a receptor gene (L-FABP

Indexed as

AnimalsDesoxycorticosteroneFatty Acid-Binding ProteinsFemaleFibrosisGene Expression RegulationHumansHypertensionKidney DiseasesLow Density Lipoprotein Receptor-Related Protein-2MiceMice, KnockoutMice, TransgenicReceptor, Angiotensin, Type 1Sodium ChlorideDesoxycorticosteroneFABP1 protein, humanFatty Acid-Binding ProteinsLow Density Lipoprotein Receptor-Related Protein-2Lrp2 protein, mouseReceptor, Angiotensin, Type 1Sodium ChlorideAng II AT1a receptorDOCAhypertensionL-FABP

Identifiers

PMID27663860
PMCPMC5161521
OpenAlexW2522021969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.